Authors: Matza, Louis S.¹; Yurgin, Nicole²; Boye, Kristina S.²; Malley, Karen³; Shorr, Jodi M.¹

Source: Current Medical Research and Opinion, Volume 23, Number 9, September 2007 , pp. 2051-2062(12)

Publisher: Informa Healthcare

Abstract:

Introduction: This study (1) used patient-reported outcome measures to assess and compare the health status of type 2 diabetes patients with and without obesity and (2) assessed the value of weight change among obese and non-obese subgroups, using standard gamble (SG) utility methodology.

Methods: Among a sample with type 2 diabetes in the United Kingdom, individuals with obesity (BMI ≥ 30 kg/m²) were identified and compared to non-obese patients. Patients completed the EQ-5D, Psychological General Well-Being Index, Appraisal of Diabetes Symptoms, and Diabetes Symptom Checklist - Revised (DSC-R). SG interviews assessed the utility of the 'basic' type 2 diabetes health state anchored to respondents' body weight, as well as health states with altered weight.

Results: A total of 129 patients (74 obese; 55 non-obese) completed interviews (mean age 55.9 years; 64.3% male). Obese patients reported lower health status (EQ-5D VAS; between-group difference: p < 0.001) and greater symptom impact (several DSC-R scales, p < 0.05). Utilities of the basic health state were 0.86 (obese) and 0.91 (non-obese; p = 0.02). Hypothetical health states with higher weight received lower utilities, whereas reduced weight was associated with increased utility. There was a between-group difference in the disutility associated with 5% higher weight (obese 0.068; non-obese 0.051; p = 0.03).

Discussion: Compared with non-obese patients, the obese group reported lower health status and greater symptom impact. SG interviews found an inverse relationship between weight and utility. Furthermore, obese patients with type 2 diabetes may value weight change differently than non-obese patients. Study limitations include the sample size and the use of a patient sample, rather than a sample selected from the general population. Overall, the results demonstrate that utilities can differ by patient subgroups, even among patients with the same diagnosis.

Keywords: OBESITY; PATIENT-REPORTED OUTCOMES (PROS); TYPE 2 DIABETES; UTILITIES

Document Type: Research article

DOI: http://dx.doi.org/10.1185/030079907X219454

Affiliations: 1: Center for Health Outcomes Research at UBC, Bethesda, MD, USA 2: Eli Lilly & Company, Indianapolis, IN, USA 3: Malley Research Programming, Inc., Rockville, MD, USA

Publication date: 2007-09-01

More about this publication?

• Information for Authors
• Subscribe to this Title
• Terms & Conditions
• General Information
• Journal Information
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Medicine (General)
• By this author: Matza, Louis S. ;  Yurgin, Nicole ;  Boye, Kristina S. ;  Malley, Karen ;  Shorr, Jodi M.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers